Impact of fibrinogen carbamylation on fibrin clot formation and stability

Veronika Binder; Brith Bergum; Stéphane Jaisson; Philippe Gillery; Carsten Scavenius; Endy Spriet; Anne Karin Nyhaug; Helen M. Roberts; Iain L. C. Chapple; Annelie Hellvard; Nicolas Delaleu; Piotr Mydel

doi:10.1160/TH16-09-0704

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2017; 117(05): 899-910
DOI: 10.1160/TH16-09-0704

Coagulation and Fibrinolysis

Schattauer GmbH

Impact of fibrinogen carbamylation on fibrin clot formation and stability

Veronika Binder^*

¹Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway

,

Brith Bergum^*

¹Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway

,

Stéphane Jaisson

²University of Reims Champagne-Ardenne, Laboratory of Biochemistry and Molecular Biology, CNRS/URCA UMR N° 7369 MEDyC, Reims, France

,

Philippe Gillery

²University of Reims Champagne-Ardenne, Laboratory of Biochemistry and Molecular Biology, CNRS/URCA UMR N° 7369 MEDyC, Reims, France

,

Carsten Scavenius

³Interdisciplinary Nanoscience Center at the Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark

,

Endy Spriet

⁴Department of Biomedicine, University of Bergen, Bergen, Norway

,

Anne Karin Nyhaug

⁴Department of Biomedicine, University of Bergen, Bergen, Norway

,

Helen M. Roberts

⁵Periodontal Research Group MRC Centre for Immune Regulation, University of Birmingham, Birmingham, UK

,

Iain L. C. Chapple

⁵Periodontal Research Group MRC Centre for Immune Regulation, University of Birmingham, Birmingham, UK

,

Annelie Hellvard

⁶Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland

,

Nicolas Delaleu

¹Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway

⁷Swiss Institute of Bioinformatics, Lausanne, Switzerland

,

Piotr Mydel

¹Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway

⁸Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland

› Author Affiliations

Abstract

Full Text

PDF Download

Keywords

Fibrinogen - carbamylation - fibrin structure

References

References
1 Walsh CT, Garneau-Tsodikova S, Gatto Jr. GJ. Posttranslational Modificaiton of Proteins. Angew Chem Int Ed Engl 2006; 44: 7342-7372.
2 Karve TM, Cheema AK. Small changes huge impact: the role of protein posttranslational modifications in cellular homeostasis and disease. J Amino Acids 2011; 2011: 207691.
3 Verbrugge FH, Wilson Tang WH, Hazen SL. Protein Carbamylation and cardiovascular disease. Kidney International 2015; 88: 474-478.
4 Gajjala RP, Fliser D, Speer T. et al. Emerging role of post-translational modifications in chronic kidney disease and cardiovascular disease. Nephrol Dial Transplant 2015; 30: 1814-1824.
5 Shi J, Knevel R, Suwannalai P. et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. PNAS 2011; 108: 17372-17377.
6 Gorisse L, Pietrement C, Vuiblet V. et al. Protein carbamylation is a hallmark of aging. PNAS 2016; 113: 1191-1196.
7 Trepanier DJ, Thibert RJ, Draisey DF. et al. Carbamylation of erythrocyte membrane proteins: an in vitro and in vivo study. Clinical Biochemistry 1996; 29: 347-355.
8 Berg AH, Drechsler C, Wenger J. et al. Carbamylation of Serum Albumin as a Risk Factor for Mortality in Patients with Kidney Failure. Sci Transl Med 2013; 05: 175ra29.
9 El-Gamal D, Holzer M, Gauster M. et al. Cyanate Is a Novel Inducer of Endothelial ICAM-1 Expression. Antioxid Redox Signal 2012; 16: 129-137.
10 Hawkins CL. Role of cyanate in the induction of vascular dysfunction during uremia: more than protein carbamylation?. Kidney Int 2014; 86: 875-877.
11 Nilsson L, Lundquist P, Kågedal R. et al. Plasma Cyanate Concentrations in Chronic Renal Failure. Clin Chem 1996; 42: 482-483.
12 Kraus LM, Kraus AP. Carabmoylation of amino acids and proteins in uremia. Kidney Int Suppl 2001; 78: S102-S107.
13 Pietrement C, Gorisse L, Jaisson S. et al. Chronic increase of urea leads to carbamylated proteins accumulation in tissues in a mouse model of CKD. PLoS One 2013; 08: e82506.
14 Jaisson S, Lorimier S, Ricard-Blum S. et al. Impact of Carbamylation on Type I Collagen Conformational Structure and Its Ability to Activate Human Polymorphonuclear Neutrophils. Chem Biol 2006; 13: 149-159.
15 Oimomi M, Hatanaka H, Yoshimura Y. et al. Carbamylation of insulin and its biological activity. Nephron 1987; 46: 63-66.
16 Koro C, Hellvard A, Delaleu N. et al. Carbamylated LL-37 as a modulator of the immune response. Innate Immun 2016; 22: 218-229.
17 Koro C, Bielecka E, Dahl-Knudsen A. et al. Carbamylation of immunoglobulin abrogates the classical pathway of complement activation. Eur J Immunol 2014; 44: 3403-3412.
18 Gillery P, Jaisson S. Post-translational modification derived products (PTMDPs): toxins in chronic diseases?. Clin Chem Lab Med 2014; 52: 33-38.
19 Bergum B, Koro C, Delaleu N. et al. Antibodies against carbamylated proteins are present in primary Sjögren’s syndrome and are associated with disease severity. Ann Rheum Dis 2016; 75: 1494-1500.
20 Jiang X, Trouw LA, van Wesemael TJ. et al. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies. Ann Theum Dis 2014; 73: 1761-1768.
21 Shi J, Willemze A, Janssen GMC. et al. Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the ”AMC-Senshu” method. Ann Rheum Dis 2012; 0: 1-3
22 Hill JA, Al-Bishri J, Gladman DD. et al. Serum autoantibodies that bind citrullinated fibrinogen are frequently found in patients with theumatoid arthritis. J Rheumatol 2006; 33: 2115-2119.
23 Jennewein C, Tran N, Paulus P. et al. Novel Aspects of Fibrino(gen) Fragments during Inflammation. Mol Med 2011; 17: 568-573.
24 Stein TP, Leskiw MJ, Wallace HW. Measurement of half-life human plasma fibrinogen. Am J Physiol 1987; 234: D504-510.
25 Weisel JW, Litvinov RI. Mechanisms of fibrin polymerisation and clinical implications. Blood 2013; 121: 1712-1719.
26 Riedel T, Suttnar J, Brynda E. et al. Fibrinopeptides A and B release in the process of surface fibrin formation. Blood 2011; 117: 1700-1706.
27 Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol 2012; 34: 43-62.
28 Sidelmann JJ, Gram J, Jespersen J. et al. Fibrin clot formation and lysis: basic mechanisms. Semin Thromb Haemost 2000; 26: 605-618.
29 Ongeri Millien V, Lu W, Shaw J. et al. Cleavage of Fibrinogen by Proteinases Elicits Allergic Responses Through Toll-Like Receptor 4. Science 2013; 341: 792-796.
30 Fattouh M, Alkady O. Inflammatory biomarkers in chronic obstructive pulmonary disease. EJCDT 2014; 63: 799-804.
31 Martinez M, Weisel JW, Ischiropoulos H. Functional Impact of oxidative post-translational modifications on fibrinogen and fibrin clots. Free Radic Biol Med 2013; 65: 411-418.
32 Wang W. Identification of Respective Lysine Donor and Glutamine Acceptor Sites Involved in Factor XIIIa-catalysed Fibrin a Chain Cross-linking. J Biol Chem 2011; 286: 44952-44964.
33 Cesarman-Maus G, Hajjar KA. Molecular mechanisms of fibrinolysis. Brit J Haematol 2005; 129: 307-321.
34 MacLean B, Tomazela D, Shulman N. et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 2010; 26: 966-968.
35 Hazeldine J, Harris P, Chapple IL. et al. Impaired neutrophil extracellular trap formation: a novel defect in the innate immune system of aged individuals. Aging Cell 2014; 13: 690-698.
36 Jaisson S, Gorisse L, Pietrement C. et al. Quantification of plasma homocitrulline using hydrophilic interaction liquid chromatography (HILIC) coupled to tandem mass spectrometry. Anal Bioanal Chem 2012; 402: 1635-1641.
37 Sobel J, Gawinowicz MA. Identification of the a Chain Lysine Donor Sites Involved in Factor XIIIa Fibrin Cross-linking. J Biol Chem 1996; 271: 19288-19297.
38 Wolberg AS, Campbell RA. Thrombin generation, fibrin clot formation and haemostasis. Transfus Apher Sci 2008; 38: 15-23.
39 Pretorius E, Oberholzer HM, van der Spuy WJ. et al. Scanning electron microscopy of fibrin networks in rheumatoid arthritis: a quantitative analysis. Rheumatol Int 2012; 32: 1611-1615.
40 Sugo T, Nakamikawa C, Yoshida N. et al. End-linked homodimers in fibrinogen Osaka VI with a Bβ-chain extension lead to fragile clot structure. Blood 2012; 96: 3779-3785.
41 Stopelli P. The Plasminogen Activation System in Cell Invasion 2013. Retrieved from Marie Curie Science Database http://www.ncbi.nlm.nih.gov/books/NBK6146
42 Lord S. Molecular mechanisms affecting fibrin structure and stability. Arterioscler Thromb Vasc Biol 2011; 31: 494-499.
43 Senior MR, Skogen WF, Griffin GL. et al. Effects of Fibrinogen Derivatives Upon the Inflammatory Response. J Clin Invest 1986; 77: 1014-1019.
44 Kalim S, Karumanchi SA, Thadhani RI. et al. Protein Carbamylation in Kidney Disease: Pathogenesis and Clinical Implications. Am J Kidney Dis 2014; 64: 793-803.
45 Holzer M, Zangger K, El-Gamal D. et al. Myeloperoxidase-derived chlorinating species induce protein carbamylation through decomposition of thiocyanate and urea: novel pathways generating dysfunctional high-density lipoprotein. Antioxid Redox Signal 2012; 17: 1043-1052.
46 Fleury V, Angles-Cano E. Characterisation of the binding of plasmin to fibrin surfaces: the role of carboxy-terminal lysines. Biochemistry 1991; 30: 7630-7638.
47 Voskuilen M, Vermond A, Veeneman GH. et al. Fibrinogen lysine residue Aa 157 plays a crucial role in the fibrin-induced acceleration of plasminogen activation, catalysed by tissue-type plasminogen activator. J Biol Chem 1987; 262: 5944-5946.
48 Scinocca M, Bell DA, Racapé M. et al. Antihomocitrullinated Fibrinogen Antibodies are Specific to Rheumatoid Arthritis and Frequently Bind Citrullinated Proteins/peptides. J Rheumatol 2014; 41: 270-279.
49 Jaisson S, Larreta-Garde V, Bellon G. et al. Carbamylation differentially alters type I collagen sensitivity to various collagenases. Matrix Biology 2007; 26: 190-196.
50 Jalal D, Chonchol M, Targher G. Disorders of Haemostasis Associated with Chronic Kidney Disease. Semin Thromb Haemost 2010; 36: 34-40.
51 Vadseth C, Souza JM, Thomson L. et al. Pro-thrombotic State Induced by Post-translational Modification of Fibrinogen by Reactive Nitrogen Species. JBC 2004; 279: 8820-8826.